

SUMMARY
Pharma Compliance Latam – 2021 is a platform for industry leaders in the region to share experiences, knowledge and understand the trends that mark the future of this industry.
The environment has changed, the Regulations got modified and outside circumstances like the Covid, have forced us to improve on the run. We want to “touch base”, make a pause and for 2 days, share best practices and learn better tools to move in along the changes and updates.
Who will
you meet?
Officers
General Counsels
Directors
Vice Presidents
From these areas:
- Ethics and Compliance
- Corporate Responsibility
- Quality Assurance
- International Contracts
- Regulatory Compliance
- Corporate Compliance
- Legal Affairs
- Internal Audit
- Business Conduct
- Transparency Operations
- Private practice Lawyers
Speaker Board

Andres Vasquez Obando
Novo Nordisk, Mexico
Legal Compliance Director
Legal Compliance Director

Valentina Mainardi
Aximport, Argentina
General Manager
General Manager

Elizabeth Rojas
Compliance GxP, Mexico
CEO / GMPs, Audits & Regulatory Affairs
CEO / GMPs, Audits & Regulatory Affairs

Alondra Diaz
Viatris, Mexico
Compliance VP
Compliance VP

Renata Fidale
Cellera Farma, Brazil
Executive Officer
Executive Officer

Diogo Mota
UCB, Brazil
Ethics and Compliance Associate Director
Ethics and Compliance Associate Director

Jose Luis Robledo
Menarini Group, Mexico
Medical Director, Pharmacovigilance & Compliance Officer
Medical Director, Pharmacovigilance & Compliance Officer

Santiago Cal y Mayor
Pfizer, Mexico
Compliance Director
Compliance Director

Pedro Fontenele Pereira
Novartis, Brazil
Financial Controls & Compliance Head
Financial Controls & Compliance Head

Mariana Fiordilino
Novo Nordisk, Argentina
Senior Legal & Compliance Director
Senior Legal & Compliance Director

Maria del Carmen Ruiz
Novartis Oncology, Mexico
Head of Legal & Compliance
Head of Legal & Compliance

Marcela Inzunza
Boehringer Ingelheim, Chile
Head of Legal & Compliance for Chile & Cluster, Corp. Lawyer
Head of Legal & Compliance for Chile & Cluster, Corp. Lawyer

Katia Rosenstein
Fresenius Medical Care, Mexico
Director of Compliance
Director of Compliance

Joelson Santos
Abbvie, Brazil
Lawyer & Corporate Governance Professional
Lawyer & Corporate Governance Professional

Claudia Correa de Miranda
Bio-Manguinhos / Fiocruz, Brazil
Regulatory Affairs Head | Regulatory Compliance
Regulatory Affairs Head | Regulatory Compliance

Carlos Lanardonne
Novartis, Argentina
Head of BD, Strategic Alliances & Est. Medicines, Novartis South Cone
Head of BD, Strategic Alliances & Est. Medicines, Novartis South Cone

Adriana Fussuma
Novartis, Brazil
Head of Ethics, Risk and Compliance
Head of Ethics, Risk and Compliance
Program at a Glance
Compliance in Pandemic times
What has changed since the lockdown and mobilization limitations
Proper communication with Third Parties
Recommendations for a healthy and clear communication with manufacturers and distribution companies
Regulatory Open Table
How can Companies and Regulatory Agencies be in the same channel
The new On-line methods
Telemedicine, webinars, quick-card and their regulations
Challenges for Multinationals
How the different commercial and cultural backgrounds per country make difficult to have the same internal legislation
Compliance trends in Latam: Risk management
How the Pharma Compliance Market will be in the next 18 months
Risk profiling
Red flags all employees should be aware

Photo Gallery from Previous Events
